Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$1.3 million.

  • Icu Medical's Exchange Rate Effect fell 11835.31% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 11217.36%. This contributed to the annual value of -$4.9 million for FY2024, which is 25583.31% down from last year.
  • Latest data reveals that Icu Medical reported Exchange Rate Effect of -$1.3 million as of Q3 2025, which was down 11835.31% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Exchange Rate Effect ranged from a high of $7.0 million in Q3 2024 and a low of -$9.4 million during Q4 2024
  • Over the past 5 years, Icu Medical's median Exchange Rate Effect value was -$1.1 million (recorded in 2021), while the average stood at -$324052.6.
  • As far as peak fluctuations go, Icu Medical's Exchange Rate Effect tumbled by 71964.29% in 2022, and later skyrocketed by 172409.64% in 2024.
  • Over the past 5 years, Icu Medical's Exchange Rate Effect (Quarter) stood at -$1.1 million in 2021, then soared by 194.33% to $999000.0 in 2022, then surged by 326.43% to $4.3 million in 2023, then tumbled by 320.68% to -$9.4 million in 2024, then surged by 86.32% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q3 2025, $6.7 million for Q2 2025, and $3.0 million during Q1 2025.